Chemoresistance remains the leading cause of treatment failure in clinical practice (Perez et al., 1990; Riganti et al., 2015), and no study has revealed the relationship between RAC1 and chemoresistance of ESCC. The gene discussed is RAC1; the disease is esophageal squamous cell carcinoma.